Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease
Joshua Quan, Christopher Ma, Remo Panaccione, Lindsay Hracs, Nastaran Sharifi, Michelle Herauf, Ante Makovinović, Stephanie Coward, Joseph W. Windsor, Léa Caplan, R Ingram, Jamil N. Kanji, Graham Tipples, Jessalyn K. Holodinsky, Çharles N. Bernstein, Douglas J. Mahoney, Sasha Bernatsky, Eric I. Benchimol, Gilaad G. Kaplan
Abstract
Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity funding reference number VR5-172684. Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). The Leona M and Harry B Helmsley Charitable Trust Grant #G-2209-05501.
Topics & Concepts
Inflammatory bowel diseaseMedicineVaccinationSerologyInflammatory Bowel DiseasesImmunologyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDiseaseVirologyInternal medicineAntibodyInfectious disease (medical specialty)OutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesInflammatory Bowel Disease